UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore ways to fund a business with no money. Unlock creative financing options and start your entrepreneurial journey now!
21,633 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Palo Alto Networks is outperforming Palantir this year, driven by AI-native security demand and margin gains, while i...
Micron Technology posted a surprisingly strong AI memory quarter, triggering debate over whether the stock’s 7x forwa...
Imagine an AI that studies your crypto habits during idle moments and preps the next move you might take. This articl...
Boeing appointed Kelly Ortberg as CEO in August 2024 to launch an inside-out turnaround. The plan focuses on quality,...
As crypto markets stabilize in 2026, traders are weighing SimpleSwap’s self-custodial model. This review examines leg...
SpaceX's Starlink is no longer just a satellite internet service. As Oppenheimer analysts suggest, it could upend a $...
A legendary film figure's passing has ignited a dispute over a $200 million boomer estate, putting liquidity and trus...
Thursday brought a notable move for AMD as shares jumped on favorable analyst commentary and a rising server CPU TAM ...
When markets wobble, investors look for guidance. This piece breaks down Warren Buffett's wisdom on market correction...
A major tech partnership and improving chip demand helped Intel stock climb sharply on Thursday. This deep dive expla...
After a string of near-misses, Netflix finally makes acquisition that seems to align with its long-term plan. This pi...